Healthcare Industry Radiofrequency Ablation Devices Market 2020 | Page 2

Your Catalyst To a Lucrative Business
On the basis of applications, the market is divided into surgical oncology, cosmetology, hypertension, pain
management, cardiac rhythm management, gynecology, and cardiology. The overall industry was led by the
surgical oncology segment in 2013. Factors that propel this market segment are high procedure volume s and
high incidence of different types of cancers. Demand for radiofrequency ablation devices for hypertension
could expand at a whopping CAGR over 26% till 2020. This attributes to huge R&D investments and demand
from patients since these devices usually do not lead to post operative complications.
Geographically, the worldwide Radiofrequency Ablation Devices Market is segmented into Asia Pacific, North
America, Europe, and Rest of the World. In 2013, North America dominated the overall industry because o f
high healthcare expenditure and sophisticated medical infrastructure. Other regional drivers are rising cases
of pain related ailments, growing aging population, and unhealthful lifestyles. In 2013, Europe held the
second highest industry share after North America.
The Asia Pacific market is poised to grow at a remarkable CAGR over 20% during the forecast period.
Favorable government initiatives and economic progress fuel regional demand. Improvements in healthcare
infrastructure in emerging economies, such as China and India could further market progress in the
forthcoming years. Extensive use of radiofrequency ablation procedures in countries, such as China, Brazil,
India, and Russia could create lucrative growth opportunities in the overall industry. Wi despread awareness
among patients and high disposable incomes are prominent factors that drive these regions.
Key industry participants in the Radiofrequency Ablation Devices Market are Biosense Webster, Kimberly -
Clark Corporation, Boston Scientific, Covidien, Diros Technology, and Stryker Corporation. In August 2016,
Boston Scientific acquired U.S. based manufacturer of RF (radiofrequency) generators and cannulae, Cosman
Medical. The main rationale of such a business venture is to develop solutions for chr onic pain via non opioid
therapeutic treatments.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-
industry
Follow Us: